• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys

tetano

Editor, Senior Moderator
Antiviral Res. 2019 Aug 14:104591. doi: 10.1016/j.antiviral.2019.104591. [Epub ahead of print]
[h=1]Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys.[/h] Arikata M[SUP]1[/SUP], Itoh Y[SUP]2[/SUP], Shichinohe S[SUP]3[/SUP], Nakayama M[SUP]3[/SUP], Ishigaki H[SUP]3[/SUP], Kinoshita T[SUP]3[/SUP], Le MQ[SUP]4[/SUP], Kawaoka Y[SUP]5[/SUP], Ogasawara K[SUP]6[/SUP], Shimizu T[SUP]1[/SUP].
[h=3]Author information[/h] 1 Department of Otorhinolaryngology, Shiga University of Medical Science, Japan. 2 Division of Pathology and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Japan. Electronic address: yasushii@belle.shiga-med.ac.jp. 3 Division of Pathology and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Japan. 4 National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. 5 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. 6 Division of Pathology and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Japan; Research Center for Animal Life Science, Shiga University of Medical Science, Otsu, Japan.

[h=3]Abstract[/h] Clarithromycin (CAM), a 14-membered ring macrolide, has anti-inflammatory and immunomodulatory actions and antiviral effects in seasonal influenza virus infection. We examined the prophylactic and therapeutic efficacy of CAM against H5N1 highly pathogenic and H7N9 low pathogenic avian influenza virus infections in cynomolgus monkeys. CAM suppressed H5N1 virus-induced severe signs of disease in the treated monkeys and inhibited virus propagation in tracheal samples and the production of inflammatory cytokines in the lungs of monkeys infected with H5N1 and H7N9 viruses. The prophylactic administration of CAM showed more suppressive effects on clinical signs of disease and viral titers than did therapeutic administration. Thus, since administration of CAM alone showed a tendency to ameliorate clinical sings and to reduce levels of inflammatory cytokines, the macrolides are expected to have effects in combination with the other antiviral drugs on the prophylactic and treatment of patients with severe avian influenza virus infection, which should be further investigated.
Copyright ? 2019. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Avian influenza virus; Clarithromycin; Cynomolgus monkey; H5N1; H7N9

PMID: 31421167 DOI: 10.1016/j.antiviral.2019.104591
 
Back
Top Bottom